Hope, Thomas A.; Afshar Oromieh, Ali; Eiber, Matthias; Emmett, Louise; Fendler, Wolfgang P.; Lawhn-Heath, Courtney; Rowe, Steven P. (2018). Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications. American Journal of Roentgenology, 211(2), pp. 286-294. American Roentgen Ray Society 10.2214/AJR.18.19957
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Hope et al..pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) |
OBJECTIVE:
The purpose of this article is to describe the large number of radiotracers being evaluated for prostate-specific membrane antigen (PSMA) PET, which is becoming a central tool in the staging of prostate cancer.
CONCLUSION:
PSMA PET is a highly promising modality for the staging of prostate cancer because of its higher detection rate compared with that of conventional imaging. Both PET/CT and PET/MRI offer benefits with PSMA radiotracers, and PSMA PET findings frequently lead to changes in management. It is imperative that subsequent treatment changes be evaluated to show improved outcomes. PSMA PET also has potential applications, including patient selection for PSMA-based radioligand therapy and evaluation of treatment response.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Afshar Oromieh, Ali |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1546-3141 |
Publisher: |
American Roentgen Ray Society |
Language: |
English |
Submitter: |
Sabine Lanz |
Date Deposited: |
10 Apr 2019 12:01 |
Last Modified: |
05 Dec 2022 15:25 |
Publisher DOI: |
10.2214/AJR.18.19957 |
PubMed ID: |
29949419 |
BORIS DOI: |
10.7892/boris.125617 |
URI: |
https://boris.unibe.ch/id/eprint/125617 |
Actions (login required)
 |
Edit item |